Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon
Thumbnail

Patients with diabetes undergoing PCI have similar outcomes whether or not they receive insulin

After risk adjustments, patients with insulin-treated diabetes and non-insulin treated diabetes who underwent PCI had similar outcomes, according to a prespecified subgroup analysis of a randomized trial. In addition, patients who received everolimus-eluting stents had better outcomes than those who received paclitaxel-eluting stents.

Palmaz Scientific faces accusations of misleading investors

Investment bank Jefferies & Co. and a bankrupt company founded by the inventor of the first heart stent are in a dispute over accusations of improper stock sales, the San Antonio Express-News reports. 

Technical and clinical success rates of PCIs for CTOs increase over time

Practice makes perfect and, for at least one expert interventional cardiologist, the old adage holds true for technical and clinical success rates of PCIs of chronic total occlusions (CTOs).

Minimally invasive mitral valve surgery appears to be superior to conventional sternotomy

Patients who underwent minimally invasive mitral valve surgery had a shorter length of stay in the intensive care unit and fewer transfusions compared with those who underwent conventional sternotomy, according to a retrospective database analysis. The procedures had similar rates of mortality, stroke and other complications and total hospital costs.

Prediction score may help identify patients who benefit from dual antiplatelet therapy following PCI

A clinical prediction score based on late ischemic and bleeding risk factors may help identify patients who may benefit or have harm from continuing to take dual antiplatelet therapy after undergoing PCI, according to a secondary analysis of a previously published study.

CMS announces facilities in Mississippi and Georgia meet standards for carotid artery stenting

The Centers for Medicare & Medicaid Services (CMS) announced that two facilities have met its standards for performing carotid artery stenting for high-risk patients.

ACC.16: CABG reduces long-term rates of death and hospitalizations in patients with ischemic cardiomyopathy

CHICAGO – After nearly 10 years of follow-up, patients with ischemic cardiomyopathy who underwent CABG and received medical therapy had significantly lower rates of death from any cause, death from cardiovascular causes and death from any cause or hospitalization for cardiovascular causes compared with patients who only received medical therapy.

ACC.16: Intermediate-risk patients have low mortality, stroke rates with the Sapien 3 TAVR valve

CHICAGO – After one year, intermediate-risk patients with severe aortic stenosis who underwent transcatheter aortic valve replacement (TAVR) with the Sapien 3 valve had better outcomes than a group that had surgical valve replacement, according to an observational study. 

Displaying 1409 - 1416 of 2710

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.